Efficacy and PK/PD of a c/EBP beta antagonist in orthotopic breast cancer
Ended Project Grant Awarded Last action
- Award ID
- R43CA250786
- Recipient
-
Sapience Therapeutics, Inc. UEI ERRLJEYAUMC8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $255,240
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $255,240 |
Quick answers
Who received award R43CA250786?
R43CA250786 was awarded to Sapience Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on August 5, 2020.
How much is award R43CA250786 worth?
$255,240 has been obligated on R43CA250786.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award